Andere talen Medical Marijuana, Inc.

Aandelen

MJNA

US58463A1051

Vertraagde tijd OTC Markets Andere beurzen 16:59:49 07-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,0023 ^USD	0,00%		-14,81%	-37,84%

2023	Medical Marijuana, Inc. (OTCPK:MJNA) heeft vrijwel alle operationele activa van KZ1 verworven voor $5 miljoen.	CI
2023	Medical Marijuana, Inc. Kondigt wijzigingen in de leiding aan	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Thinking about buying stock in Inpixon, Medical Marijuana, Hello Group, Vroom, or Heritage Insurance Holdings?	15/03
AXIM Biotechnologies, Inc. announced that it expects to receive $0.75 million in funding from Medical Marijuana, Inc.	26/12
Medical Marijuana, Inc. acquired Essentially all Operating Assets of KZ1 for $5 million.	01-08-23
Medical Marijuana, Inc. Announces Executive Changes	14-03-23
Medical Marijuana, Inc. Appoints Dr. Timothy R. Scott as Its New Chief Executive Officer	14-03-23
Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion	14-03-23
Medical Marijuana, Inc. Participates in Preclinical Research Study on Therapeutic Benefits of CBD on Traumatic Brain Injuries	06-02-23
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point	24-01-23
Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology	29-11-22
Medical Marijuana, Inc. Reports $4.9 Million in Net Revenue in 2022 Third Quarter Financial and Operational Results	22-11-22
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets	01-11-22
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Celebrates Successful Sponsorship of 2022 XII Latin American Congress of Epilepsy in Medellin, Colombia	20-10-22
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson's Disease Treatment	12-10-22
Medical Marijuana, Inc. Enters Into Asset Purchase Agreement With MFINITY Global LLC; Appoints MFINITY President as Kannaway President	04-10-22
Medical Marijuana, Inc. Signs Deal With Leading European Manufacturer and Distributor to Expand Channel Access to Products Throughout the Region	08-09-22
Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 Second Quarter Financial and Operational Results	18-08-22
Medical Marijuana, Inc. Subsidiary HM Pharma Submits CBD Product Dossier; Receives Sanitary Registration in Brazil	11-08-22
GRN Holdings Corporation, Inc. (OTC: GRNF) Announces Name Change to Marijuana Inc., New Management and Business Model	05-08-22
Medical Marijuana, Inc. CEO Provides Insight on Future of U.S. Cannabis Market in Nasdaq News	26-07-22
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Health & Wellness Podcast; Secures Features in Top Brazil Lifestyle Publications	14-07-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Medical Marijuana, Inc.

Aandelen

MJNA

US58463A1051

Andere talen

Filters